31 Mar 2022
Assets2,164.23
Total Income897.74
Profit After Tax6.23
NET Worth877.76
Reserves and Surplus859.17
Total Borrowing751.32
Open 11th Dec 2024 · Close 13th Dec 2024 · Listing 18th Dec 2024
The shares listed at ₹650.00, a 18.40% move from the issue price. Sai Life Sciences is a Mainboard IPO with an issue size of ₹3,042.62 crore, proposed for listing on BSE, NSE. The offer opens on 11th Dec 2024 and closes on 13th Dec 2024. The issue structure includes a fresh issue of ₹950.00 crore and an offer-for-sale component of ₹2,092.62 crore. The current listing schedule points to 18th Dec 2024.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 27 | ₹14,823 |
| Object | Amount |
|---|---|
| Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by our Company | ₹720.00 Cr |
| General corporate purposes | ₹198.98 Cr |
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 11.79% |
| ROCE | 15.96% |
| RoNW | 8.13% |
| PAT Margin | 5.65% |
| Price to Book Value | 10.18 |
| Expense | Amount |
|---|---|
| BRLM's fees (including brokerage and selling commission) | ₹72.99 Cr |
| Commission/processing fee for SCSBs, Sponsor Banks and Bankers to the Offer. Brokerage and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | ₹8.83 Cr |
| Fees payable to Registrar to the Offer | — |
| Fees payable to the other parties to the Offer, including Statutory Auditors, Independent Chartered Accountant, industry expert, and fees payable to legal counsel | ₹28.60 Cr |
| Advertising and marketing expenses for the Offer | ₹6.71 Cr |
| Listing fees, SEBI filing fees, upload fees, BSE and NSE processing fees, book building software fees and other regulatory expenses | ₹7.49 Cr |
| Printing and stationery | ₹3.03 Cr |
| Miscellaneous | ₹0.83 Cr |